Fester
发表于 2025-3-28 18:27:50
Testosterone,seen in young men with low testosterone levels and the major changes reported in older males, there has been a reluctance to pursue hormonal replacement therapy in the male. Why is this the case? Although there are clearly many contributory reasons, it seems that the major reason was, until recently
成绩上升
发表于 2025-3-28 18:49:10
http://reply.papertrans.cn/31/3098/309764/309764_42.png
花束
发表于 2025-3-29 00:34:46
Menopause,asing societal health issue: care of elderly women. Most women can now expect to live 25–30 yr beyond their menopause (.). Thus, female longevity is no longer a major issue, but the quality of this expanded life-span, certainly is. The solution to the burgeoning cost of menopause-related conditions
FEMUR
发表于 2025-3-29 03:21:27
http://reply.papertrans.cn/31/3098/309764/309764_44.png
广告
发表于 2025-3-29 09:07:40
Evaluation and Management of Obesity in the Elderly,lder individuals is also increasing rapidly, and makes up more than 12% of the total population, encompassing approx 30 million people in the United States (.). Obesity is associated with a wide range of adverse health consequences resulting in considerably increased morbidity and mortality (.). The
抛弃的货物
发表于 2025-3-29 14:01:00
http://reply.papertrans.cn/31/3098/309764/309764_46.png
六个才偏离
发表于 2025-3-29 17:52:09
Metabolic and Cardiovascular Factors Contributing to Hypertension in the Elderly,yr of age (.). Although coronary heart disease (CHD) is less common in women than men (.), CHD, including heart disease and stroke, is the leading cause of death in women older that 50 yr (.). Over 200,000 women between the ages of 50 and 79 yr die of CHD in the United States each year (.). Thus, CH
Cognizance
发表于 2025-3-29 20:28:20
http://reply.papertrans.cn/31/3098/309764/309764_48.png
青少年
发表于 2025-3-30 00:55:00
http://reply.papertrans.cn/31/3098/309764/309764_49.png
vasculitis
发表于 2025-3-30 06:51:53
RMAB in Opportunistic Scheduling,y uncertain, and may vary from specialist to specialist. There are no agreed investigation protocols, for diagnosing osteoporosis and the treatment tends to be arbitrary and stereotyped. There have been many excellent trials, but their clinical application is slow, and clinical results are seldom published.